Physical Therapists in Robesonia, PA Accepting Medicare
14 Physical Therapists found. Showing 1 - 14
 Western Berks Physical Therapy Inc. Physical Therapist Medicare: Medicare Enrolled Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
 Elizabeth Lawrey, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 |
 Daniel Scott Hassell, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
Mr. Kevin Walter Krause, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
Adam George Broad, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2663 Fax: 610-589-2232 |
Deborah Rae Mckim, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
Laura Dawson Cahan, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
Mark Taylor Grandinetti, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
Ashley N Shirk, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
Karen Elizabeth Keenan, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
Amber Lynn Fake, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
Daniel Reed, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
Joelle N Winey, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 Fax: 610-589-2232 |
Lindsay Bollinger Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1011 W Penn Ave, Robesonia, PA 19551 Phone: 610-589-2263 |
News Archive
Pfizer to discontinue commercial availability of Mylotarg for AML in U.S.
Pfizer Inc. announced today that based on discussions with the U.S. Food and Drug Administration (FDA), it will be discontinuing commercial availability of Mylotarg® (gemtuzumab ozogamicin for Injection) (used for the treatment of relapsed acute myeloid leukemia (AML)) in the United States and that it will be voluntarily withdrawing the new drug application (NDA) for Mylotarg effective October 15, 2010.
Astellas commences unsolicited tender offer to acquire common shares of OSI for $52.00 per share
OSI Pharmaceuticals, Inc. today confirmed that Astellas Pharma Inc. has commenced an unsolicited tender offer to acquire all outstanding common shares of OSI for $52.00 per share in cash.
New tool accurately predicts risks of death, complications from obesity and diabetes
A new web-based risk calculator can accurately predict the likelihood a patient with type 2 diabetes and obesity will die or develop serious complications including a heart attack, heart failure and diabetic kidney disease (nephropathy) within the next 10 years.
NexMed's NexACT technology enhances Taxol's bioavailability through oral administration
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, today announced that pre-clinical results from its research and development group at Bio-Quant successfully demonstrated the ability of the NexACT technology to deliver an oral formulation of Taxol® (paclitaxel) and to enhance the drug's bioavailability by approximately ten-fold through this oral administration. Taxol, a first line chemotherapy drug used to treat breast, lung and ovarian cancers, is currently administered through an intravenous infusion that can take up to 24 hours to complete.
Warburg Pincus to invest CDN $35 million in Protox
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins for the treatment of diseases of the prostate and cancer, and Warburg Pincus, a leading global private equity firm, today jointly announced that they have entered into an Investment Agreement.
› Verified 1 days ago